Zevra Therapeutics (ZVRA) Q2 2024 Earnings

8MayConfirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
-0.47
-0.36
-0.26
-0.15

Details

Expected EPS
-0.466667
Actual EPS
-0.4
Surprise EPS
0.07
Surprise Percent
+14.29%

Description

Zevra Therapeutics (ZVRA) has reported earnings of -0.4 per share for Q2 2024.

0 Comments

Share your thoughts